Evidence map›Paper›PMID 31611350›Full record

ArticleAntimicrobial agents and chemotherapy2019

Regulation and Anaerobic Function of the

Brindar K Sandhu, Adrianne N Edwards, Sarah E Anderson, Emily C Woods, Shonna M McBride

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. CenIR, an essential BlaIR-family regulatory system inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Clostridioides difficile pathogenesis and control.Nature reviews. Microbiology · 2026
    Review
  6. Biomedicines · 2025
    Review
  7. Article
  8. Article
  9. One health (Amsterdam, Netherlands) · 2024
    Article
  10. The pH-responsive SmrR-SmrT system modulatesInfection and immunity · 2024
    Article
  11. Antibiotic Resistances of Clostridioides difficile.Advances in experimental medicine and biology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Antimicrobial resistance in Clostridioides difficile.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Review
  16. Mechanisms of antibiotic resistance of Clostridioides difficile.The Journal of antimicrobial chemotherapy · 2021
    Review
  17. Microorganisms · 2021
    Review
  18. ACS infectious diseases · 2021
    Article
  19. Inhibition of theACS infectious diseases · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brindar K SandhuDepartment of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA.
Adrianne N EdwardsDepartment of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA.
Sarah E AndersonDepartment of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA.
Emily C WoodsDepartment of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA.
Shonna M McBrideDepartment of Microbiology and Immunology, Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, Georgia, USA shonna.mcbride@emory.edu.ORCID 0000-0001-6221-714X
Emory University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Host-induced Initiation of Clostridium difficile SporulationR01AI116933 · NIAID · EMORY UNIVERSITY · PI SHONNA M. MCBRIDE · 2015 to 2026
$4.8M
Antimicrobial Resistance and Therapeutic Discovery Training ProgramT32AI106699 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn, Joanna B Goldberg · 2014 to 2026
$2.7M
Polymeric Agents for the Treatment of Clostridium difficile InfectionsR33AI121684 · NIAID · EMORY UNIVERSITY · PI GELLMAN, SAMUEL H., MCBRIDE, SHONNA M. · 2018 to 2020
$1.4M
Polymeric Agents for the Treatment of Clostridium difficile InfectionsR21AI121684 · NIAID · EMORY UNIVERSITY · PI GELLMAN, SAMUEL H., MCBRIDE, SHONNA M. · 2016 to 2017
$415k
NIAID NIH HHS R01 AI116933NIAID NIH HHS R21 AI121684NIAID NIH HHS R33 AI121684NIAID NIH HHS T32 AI106699NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnaerobiosisBacterial Proteinsbeta-Lactamasesbeta-LactamsClostridioides difficileDrug Resistance, MicrobialLipoproteinsBacterial Proteinsbeta-Lactamasesbeta-LactamsLipoproteinsantibiotic resistanceblaRIClostridioides difficileClostridium difficileβ-lactamaseβ-lactam resistance

Identifiers

PMID31611350
PMCPMC7187622
OpenAlexW2979400006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.